CD56 positive intestinal T-cell lymphoma: Treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation

Mitsutaka Okuda, Jun Nomura, Hiroo Tateno, Junichi Kameoka, Takeshi Sasaki

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

A 63-year-old man presented with a perforation of the small intestine. A diagnosis of intestinal T-cell lymphoma (ITCL) was made from CD (cluster differentiation) 3 positivity and a rearrangement of T-cell receptor genes. The tumor also expressed CD56, which suggests it belongs to a rare subtype derived from activated cytotoxic intraepithelial T lymphocytes. Although the prognosis of ITCL has been considered to be very poor irrespective of CD56 positivity, complete remission was achieved in this case by high dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT) even after relapse. Auto-PBSCT in the earlier stage of the disease might improve the prognosis.

Original languageEnglish
Pages (from-to)734-737
Number of pages4
JournalInternal Medicine
Volume41
Issue number9
DOIs
Publication statusPublished - 2002 Sep 1

Keywords

  • Autologous peripheral blood stem cell transplantation
  • Jejunostomy
  • Natural killer cell-like
  • Perforation of jejunem

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'CD56 positive intestinal T-cell lymphoma: Treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation'. Together they form a unique fingerprint.

Cite this